Mutational Analysis of the Interaction between 14-3-3 Proteins and Plant Plasma Membrane H+-ATPase*

Sabina ViscontiDagger , Lorenzo CamoniDagger , Maria Rosaria Fullone§, Marco LalleDagger , Mauro Marra, and Patrizia AducciDagger ||

From the Dagger  Department of Biology, University of Rome "Tor Vergata," via della Ricerca Scientifica, I-00133, Rome, Italy, § Department of Biochemical Sciences "A. Rossi-Fanelli," University of Rome "La Sapienza," piazzale Aldo Moro 5, I-00185 Rome, Italy, and  Department of Biological and Environmental Studies, University of Sannio, via Port'Arsa 11, I-82100, Benevento, Italy

Received for publication, October 29, 2002, and in revised form, December 10, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In this study, we report on mutational studies performed to investigate the mechanism of binding of 14-3-3 proteins to the plasma membrane H+-ATPase of plant cells. In fact, although the molecular basis of the interaction between 14-3-3 and the known mode-1 and mode-2 consensus sequences are well characterized, no information is available regarding the association with the H+-ATPase, which contains the novel binding site YTV totally unrelated to the 14-3-3 canonical motifs. To this purpose, different mutants of the maize 14-3-3 GF14-6 isoform were produced and used in interaction studies with the plasma membrane H+-ATPase and with a peptide reproducing the 14-3-3 binding site of the enzyme. The ability of 14-3-3 mutants to stimulate H+-ATPase activity was also tested. To investigate the mechanism of fusicoccin-dependent interaction, binding experiments between 14-3-3 proteins and mutants of the extreme portion of the H+-ATPase C terminus were also carried out. The results demonstrate that mutations of Lys56 and Val185 within the amphipathic groove disrupt the ability of GF14-6 to interact with H+-ATPase and to stimulate its activity. Moreover, substitution of Asp938 and Asp940 in the MHA2 H+-ATPase C terminus greatly decreased association with GF14-6, thereby demonstrating a crucial role of negatively charged residues in the fusicoccin-dependent interaction.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

14-3-3 are a family of highly conserved proteins widespread in eukaryotic organisms. A number of biological activities have been attributed to 14-3-3, including the control of cell cycle, differentiation, apoptosis, targeting of proteins to different cellular locations, and the coordination of multiple signal-transduction pathways (1-7). The common feature of 14-3-3 proteins is the ability to bind target proteins, and this accounts for their diverse regulatory functions (2, 3, 6). Most 14-3-3-interacting proteins bind their targets in a phosphorylation-dependent manner. Muslin et al. (8) suggested a consensus motif RSXSpXP (Sp indicates a phosphoserine) found in several proteins known to associate with 14-3-3 proteins. This sequence has been defined in more detail by peptide library screening: two different phosphoserine motifs, R[S/Ar][+/Ar]Sp[L/E/A/M]P and RX[S/Ar][+]Sp[L/E/A/M]P (where Ar indicates an aromatic residue and + a basic residue), defined as mode-1 and mode-2 sequences respectively, were proposed (9). However these motifs cannot account for all 14-3-3 interactions and, even though phosphorylation seems to be a general prerequisite for 14-3-3 binding, proteins interacting in a phosphorylation-independent manner have also been identified (10-12).

The 14-3-3 dimers have a characteristic cup-like shape with a highly conserved inner surface and a more variable outer surface (13, 14). In the concave surface, each monomer presents an amphipathic groove formed by a cluster of basic residues (Lys49, Arg56, Lys120, Arg127) on one side, and hydrophobic residues (Val176, Leu216, Leu220, Leu227) on the other side. Crystallization studies of 14-3-3zeta with phosphorylated peptides reproducing mode-1 consensus sequence demonstrated that phosphoserine interacts by salt bridges with the side chains of basic residues of the 14-3-3 groove (9, 15). Accordingly, mutations of Lys49, Arg56, and Arg60 hamper the association of 14-3-3zeta with Raf-1 and exoenzyme S (16). Substitution of residues in the hydrophobic cluster also affects binding properties (17).

In plants, much less information about the mechanism of interaction between 14-3-3 proteins and their targets is available. Most of the binding sequences so far identified are ascribable to the mode-1 motif (2, 7). A remarkable exception is represented by the plasma membrane H+-ATPase. In fact, it contains, at the extreme end of its C-terminal domain, the 14-3-3 binding site YTV (18), which is totally unrelated to those previously identified. Phosphorylation of the threonine residue in the YTV sequence, which has been demonstrated to occur in vivo (19), is required for the interaction with 14-3-3 proteins (18, 20). Association of 14-3-3 proteins with the H+-ATPase is stabilized by the toxin fusicoccin (FC)1, known to strongly activate the H+-ATPase (21). Moreover, FC is able to trigger the interaction of 14-3-3 with the H+-ATPase also in the absence of phosphorylation (22).

Here we report on mutational studies carried out to elucidate the molecular basis of the interaction between 14-3-3 proteins and the plasma membrane H+-ATPase of plant cells. Different mutants of the maize 14-3-3 GF14-6 isoform (K56E, K56Q, K56R, and V185E) were produced and used in interaction studies with the plasma membrane H+-ATPase and with a peptide reproducing the 14-3-3 binding site of the enzyme. The ability of 14-3-3 mutants to stimulate the phosphohydrolytic activity of the H+-ATPase was also tested and correlated to the interaction data. Finally, to investigate the mechanism of the FC-dependent interaction, binding experiments between 14-3-3 proteins and mutants of the extreme portion of the H+-ATPase C terminus were carried out.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Chemicals-- FC was prepared according to Ballio et al. (23); tritiated dihydroFC ([3H]FC) with specific activity 0.77 TBq/mmol was obtained according to Ballio et al. (24).

[gamma -32P]ATP (specific activity 110 TBq/mmol) and thrombin were from Amersham Biosciences (Upssala, Sweden). Protein kinase A, catalytic subunit, was from Sigma. bL15Vp peptide biotynil-LKGLDIDTIQQNYTpV (Tp, phosphothreonine) and MHA2-776p peptide biotynil-ALIFVTRSRSpWSFVE (Sp, phosphoserine) were synthesized by Neosystem (Strasbourg, France). Chemicals for gel electrophoresis were from Bio-Rad (Hercules, California, USA). All other reagents were of analytical grade.

Plant Material-- Maize seeds (Zea mays L. cv. Santos) from Dekalb (Mestre, Italy) were germinated and grown in the dark for 6 days, as already described (25).

Escherichia Coli Strains-- E. coli strains were grown at 37 °C in LB liquid medium or agar plates (15 g/l). Ampicillin was used at concentration of 100 µg/ml. Strain DH5alpha was used for plasmid propagation and strain BL21(DE3) was used for protein expression.

Site-directed Mutagenesis of 14-3-3 Protein-- pGEX-2TK carrying the GF14-6 cDNA (pX18 DNA clone) was used as a template for mutagenesis of GF14-6 14-3-3 protein. Site-directed mutagenesis of Lys56 was obtained by PCR amplification of the 108-787 fragment using a 5' oligonucleotide primer containing the desired mutations and SacI restriction site and a 3' oligonucleotide primer containing EcoRI restriction site complementary to the 3' end of GF14-6 cDNA. PCR product was directly cloned in pGEM-T vector (Promega, Madison, Wisconsin, USA) and, after sequencing, the mutated SacI-EcoRI fragment was recovered and subcloned in SacI-EcoRI cut pX18.

Mutagenic primers used were (mutations generated are underlined and restriction sites are in lowercase): Lys56 right-arrow Glu, 5'-gagctcACTGTGGAGGAGCGAAACCTCTTGTCTGTTGCATACGAGAAC-3'; Lys56 right-arrow Gln, 5'-gagctcACTGTGGAGGAGCGAAACCTCTTGTCTGTTGCATAC CAGAAC-3'; Lys56 right-arrow Arg, 5'-gagctcACTGTGGAGGAGCGAAAC CTCTTGTCTGTTGCATACAGGAAC-3'; 3' primer, 5'-gaattcCTTACTGCCCCTCGCTCGAGTCCCGCTTG-3'.

Site-directed mutagenesis of Val185 was performed by using the QuikChange site-directed mutagenesis method (Stratagene, La Jolla, CA). The mutagenic primers used were (mutation generated is underlined): coding primer 5'-TTAACTTCTCAGAGTTCTACTATGAGATTCTG-3'; complementary primer 5'-CATAGTAGAACTCTGAGAAGTTAAGTGCCA-3'. After 18 cycles of PCR (30 s at 95 °C, 1 min at 53 °C, 11 min 40 s at 68 °C), 10 units of DpnI were added to the mixture to digest the pX18 DNA template, and reaction was carried out at 37 °C for 2 h. 20 µl of the mixture were used to transform E. coli DH5alpha competent cells. Incorporation of mutation was controlled by DNA sequencing.

Site-directed Mutagenesis of the H+-ATPase C-terminal Domain-- pGEX-2T carrying the cDNA fragment encoding the last 103 amino acid residues of the H+-ATPase MHA2 isoform (Maize H+-ATPase isoform 2) (pGEX-E DNA clone) (22) was used as a template. Mutagenesis was obtained by PCR using mutagenic oligonucleotide primers complementary to the 3' end of the cDNA fragment, containing the desired mutations and EcoRI restriction site, and a primer based on the 5' end of the cDNA fragment corresponding to 2738-2752 region of the MHA2 gene (26) containing BamHI restriction site.

Mutagenic primers were (mutations generated are underlined and restriction sites are in lowercase): Glu938 right-arrow Ala, 5'-gaattcTCACACCGTGTAGTTCTGCTGGATGGTGTCGA-TGGCCAG-3'; Glu940 right-arrow Ala, 5'-gaattcTCACACCGTGTAGTTCTGCTGGATGGTGGCGATGTCCAG-3'; Glu938 and Glu940 right-arrow Ala, 5'-gaattcTCACACCGTGTAGTTCTGCTGGATGGTGGCGATGGCCAG-3'; Thr947 right-arrow Glu, 5'-gaattcTCACACCTCGTAGTTCTGCTGG-3'; 5' primer, 5'-GCGggattcAGCGGCAGG GCATGG-3'.

Expression in E. coli of Recombinant Proteins-- Wild-type and mutated GF14-6 proteins were expressed in E. coli as fusion proteins with the glutathione-S-transferase (GST) using pGEX-2TK vector, whereas wild-type and mutant C-terminal domain of MHA2 H+-ATPase were expressed as GST-fusion proteins using pGEX-2T vector, following the procedure described by Fullone et al. (22).

Isolation of Maize Plasma Membranes-- Two-phase partitioned plasma membranes from maize roots were obtained as previously described (25).

Purification of ER from Yeast Expressing AHA1-- Plasma membrane H+-ATPase AHA1 isoform (Arabidopsis thaliana H+-ATPase isoform 1) was expressed in Saccharomyces cerevisiae as previously described (27). After cell homogenization, membranes were purified by differential centrifugation and ER, containing most of the AHA1, was isolated by sucrose gradient centrifugation (28).

SDS-PAGE and Overlay Assay-- SDS-PAGE was performed as described by Laemmli (29), in a Mini Protean apparatus (Bio-Rad).

The system used for expression of wild-type and mutated GF14-6 proteins produces a GST-fused 14-3-3 containing a cAMP-dependent protein kinase phosphorylation site and a thrombin site between the two polypeptides. The 32P-labeled wild-type and mutated GF14-6 were obtained as described (22). Specific activities of all the labeled proteins were similar (about 3 MBq/mg).

The overlay assay was carried out according to Fullone et al. (22), with minor modifications. Briefly, two-phase partitioned maize plasma membranes (10 µg protein) containing the H+-ATPase, wild-type and mutated GST-C-terminal domain of the MHA2 (1 µg) or wild-type and mutated GF14-6 proteins (0.5 µg) were subjected to SDS-PAGE and blotted onto nitrocellulose membrane, using a semidry LKB apparatus (2 h, 0.8 mA cm-2). The membrane was blocked with 5% fatty acid-free milk in 25 mM Hepes-OH, 75 mM KCl, 5 mM MgCl2, 1 mM dithiothreitol, 0.1 mM EDTA, 0.05% Tween 20, pH 7.5 (buffer H) and then incubated overnight at 4 °C in the same buffer containing 2% fatty acid-free milk, 3 µg of 32P-labeled wild-type or mutated GF14-6 proteins (corresponding to 9 kBq/ml) and, where indicated, 10 µM FC. After incubation, the membrane was washed three times with buffer H, dried, and subjected to autoradiography at -80 °C. Each overlay experiment was performed at least three times, and similar results were obtained.

Binding of GF14-6 to Resin-bound Phosphopeptides-- 0.5 nmol of bL15Vp or MHA2-776p peptides were immobilized onto 40 µl of streptavidin-agarose resin (Sigma) and incubated in 50 µl of buffer H along with 3 µg of 32P-labeled wild-type or mutated GF14-6 (1.4 kBq/µg) for 60 min at room temperature in the absence or in the presence of 10 µM FC. Resin was then centrifuged at 2000 × g for 5 min and washed three times with 1 ml of buffer H containing, where indicated, 10 µM FC. Resin-bound radioactivity was measured in a liquid scintillation beta  counter (LKB Wallac 1410).

[3H]FC Binding Assay to the 14-3-3/Phosphopeptide Complex-- bL15Vp and MHA2-776p peptides were immobilized onto the streptavidin-agarose resin, in the conditions already described, and incubated for 60 min at room temperature with 10 µg of wild-type or mutated GST-GF14-6 proteins in the presence of 30 nM [3H]FC, in 100 µl of buffer H. After three washes with 1 ml of buffer H, resin was added to 10 ml of scintillation liquid and radioactivity was measured in the beta  counter (LKB Wallac 1410). Specific binding was calculated subtracting to the total [3H]FC-binding the value measured in the presence of 10 µM FC.

ATPase Activity-- AHA1 phosphohydrolitic activity of yeast ER membranes was assayed according to Marra et al. (28) with minor modifications: 10 µg of sucrose gradient purified yeast ER were preincubated with different concentrations of wild-type or GF14-6 mutants (ranging from 0 to 1 µM) in 500 µl of 50 mM Tris-Mes, 5 mM MgCl2, 50 mM KNO3, 5 mM NaN3, 0.2 mM ammonium molybdate and 10 µM FC, pH 7.2 (buffer A). After 20 min incubation, 2 mM ATP was added. ATP hydrolysis was measured according to Serrano (30).

Analytical Methods-- Protein concentration was determined by the method of Bradford (31) using bovine serum albumin as the standard.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

K56E and V185E Mutations Do Not Result in Significant Structural Changes of GF14-6-- In the 14-3-3zeta isoform, mutations of Lys49 and Val176 have been reported to drastically reduce the interaction with the prototype consensus motif of Raf-1 (16, 17). To verify whether the association between plant 14-3-3 proteins and the peculiar YTpV binding sequence of the H+-ATPase shares the same mechanism, we generated the corresponding mutations of the maize 14-3-3 isoform GF14-6. In Fig. 1 the alignment of 14-3-3zeta and GF14-6 isoforms shows that Lys49 and Val176 residues in 14-3-3zeta correspond to Lys56 and Val185, respectively, in GF14-6. K56E and V185E mutants were expressed in E. coli as GST-fusion proteins. The overall structure integrity of mutant proteins was examined by circular dichroism analysis and by testing their ability to dimerize. CD spectra of mutants overlapped that of wild-type protein (data not shown). To check the dimerization properties of mutants, overlay assay experiments were carried out. In this system, 32P-labeled GF14-6 wild-type, K56E, and V185E proteins were used as probes and the same unlabeled proteins, immobilized on nitrocellulose membrane, as baits. Autoradiography, reported in Fig. 2, shows that both 32P-labeled mutated proteins were able to interact each other and with the wild-type, demonstrating that the ability of mutants to form dimers was unaffected.


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 1.   Alignment between the Zea mays 14-3-3 GF14-6 isoform and the mammalian 14-3-3zeta isoform. 14-3-3zeta residues Lys49 and Val176, corresponding to Lys56 and Val185 in GF14-6, are indicated in bold.


View larger version (47K):
[in this window]
[in a new window]
 
Fig. 2.   Dimerization properties of GF14-6 mutants. Overlay assay was carried out with wild-type and mutant proteins treated with thrombin to remove GST. 0.5 µg of K56E, V185E, and wild-type GF14-6 were subjected to SDS-PAGE, and, after blotting, nitrocellulose membranes were incubated with 32P-labeled wild-type GF14-6 (a), 32P-labeled K56E mutant (b) or 32P-labeled V185E mutant (c), in the conditions indicated under "Experimental Procedures."

K56E and V185E Mutations hamper the interaction of GF14-6 to the H+-ATPase-- The effect of K56E and V185E mutations on the association of 14-3-3 proteins with the H+-ATPase was investigated by means of the overlay assay. 32P-labeled K56E, V185E, and wild-type GF14-6 proteins were used as probes and the H+-ATPase from maize roots as a bait. The results of autoradiography are reported in Fig. 3a. K56E (2) and V185E (3) mutations severely hampered the association of 14-3-3 protein with the H+-ATPase. Binding of mutants, compared with wild-type, is reduced also in the presence of FC (Fig. 3a), which is known to strongly increase association of 14-3-3 with the H+-ATPase (22).


View larger version (59K):
[in this window]
[in a new window]
 
Fig. 3.   Effect of mutations K56E and V185E of GF14-6 on its interaction with the H+-ATPase. The overlay assay was performed subjecting 10 µg of plasma membrane proteins (a) or 1 µg of recombinant MHA2 GST-C terminus (b) to SDS-PAGE. After blotting, nitrocellulose membranes were incubated with 32P-labeled wild-type GF14-6 (lane 1), 32P-labeled K56E (lane 2), or 32P-labeled V185E (lane 3) in the absence or in the presence of 10 µM FC.

It is known that 14-3-3 proteins can interact with the H+-ATPase also in a phosphorylation-independent manner. In these conditions, the association is completely dependent on FC (18, 20, 22). To verify whether K56E and V185E mutations affect also this interaction, the ability of mutated proteins to bind the recombinant C-terminal domain of H+-ATPase, expressed in E. coli as a GST-fusion protein, was tested. As shown in Fig. 3b, for both mutants, the interaction with the C-terminal domain of the H+-ATPase was almost completely abolished.

Lys56 Mutations Suggest a Role for a Positive Charge in the Interaction with the H+-ATPase-- The relevance of the contribution of Lys56 to the H+-ATPase binding was further studied by mutating it in Gln and Arg and expressing the mutated GST-fusion proteins in E. coli.

The effect of mutations on the interaction was tested by overlay experiments. As reported in Fig. 4a, substitution of Lys56 with the polar residue Gln only partially restored the binding activity (3). On the other hand, the interaction with the H+-ATPase was completely rescued by the conservative mutation K56R (4). The results demonstrate that the positive charge is also required in the FC-dependent interaction; in fact, K56Q mutant showed a very weak interaction with both H+-ATPase (Fig. 4a) and its C-terminal domain (Fig. 4b).


View larger version (47K):
[in this window]
[in a new window]
 
Fig. 4.   Effect of different mutations of Lys56 on the interaction of GF14-6 with the H+-ATPase. The overlay assay was performed under the same conditions described in the legend of Fig. 3, using the full-length H+-ATPase (a) or its recombinant C-terminal domain (b) as baits in the absence or in the presence of 10 µM FC. Lane 1, 32P-labeled wild type GF14-6; lane 2, 32P-labeled K56E; lane 3, 32P-labeled K56Q; lane 4, 32P-labeled K56R.

Lys56 and Val185 Mutations Affect the Interaction of GF14-6 with Peptides Reproducing 14-3-3 Binding Sites of H+-ATPase-- A phosphorylated biotinyl-peptide (bL15Vp) reproducing the last 15 amino acid residues of the MHA2 H+-ATPase and containing the 14-3-3-YTpV binding sequence was used in interaction studies with GF14-6 mutants. The peptide was immobilized onto a streptavidin-agarose resin and incubated with 32P-labeled wild-type and mutant proteins. Interestingly, the results, reported in Fig. 5, were only partially in accordance with those obtained by overlay assays. In fact, although, as expected, K56E and V185E mutants did not interact with bL15Vp peptide and K56Q interacted very weakly, the conservative mutant K56R bound bL15Vp more efficiently than the wild-type GF14-6 did.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 5.   Binding of wild-type and mutant GF14-6 proteins to bL15Vp and MHA2-776p phosphopeptides. Peptides were immobilized onto streptavidin-agarose resin and incubated with 32P-labeled wild-type or mutant GF14-6 in the absence or in the presence of 10 µM FC. After washing, radioactivity associated with resin was measured. Data are the mean of three independent experiments.

The same binding experiments were carried out with a phosphorylated peptide (MHA2-776p) reproducing a putative 14-3-3-binding site located in the cytosolic stretch between the 8 and 9 helices of the MHA2 H+-ATPase. This peptide contains the mode-1 related sequence RSRSpWS, and it has been reported to interact with GF14-6 protein (28); however, the physiological relevance of this interaction has not yet been demonstrated.

The results were substantially in accordance with those obtained with bL15Vp peptide. Yet a remarkable difference was observed when the experiments were performed in the presence of FC; in fact, whereas FC strongly stabilized the bL15Vp/14-3-3 complexes, it was completely ineffective on the MHA2-776p/14-3-3 interaction (Fig. 5). These data were confirmed by assaying the ability of peptides/14-3-3 complexes to bind a tritiated derivative of FC. In fact, as reported in Fig. 6, only the complexes between bL15Vp peptide and wild-type GF14-6, or K56R mutant, were able to bind [3H]FC.


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 6.   [3H]FC binding to peptides/GF14-6 proteins complexes. bL15Vp and MHA2-776p peptides were immobilized onto streptavidin agarose beads and incubated with wild-type or mutated GF14-6 proteins in the presence of 30 nM [3H]FC. Data are the mean of three independent experiments.

Lys56 and Val185 Mutations Affect 14-3-3-induced Stimulation of H+-ATPase-- The effect of Lys56 and Val185 mutations on the in vitro activation of the H+-ATPase induced by 14-3-3 proteins was tested by using purified ER vesicles of S. cerevisiae expressing the H+-ATPase AHA1 isoform of Arabidopsis thaliana. In this system, a significant and reproducible stimulation of H+-ATPase can be obtained by exogenous 14-3-3 proteins, provided that FC is also added.

ER membranes were incubated with different amounts of wild-type or mutated GF14-6 proteins in the presence of 10 µM FC. The results, reported in Fig. 7, demonstrate that the ability to stimulate the H+-ATPase activity depends on the ability to associate with it. In fact, only the wild-type and K56R GF14-6, which efficiently bound H+-ATPase in the interaction experiments (Fig. 4), stimulated AHA1 phosphohydrolytic activity.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 7.   Effect of mutations of Lys 56 and Val 185 on the ability of GF14-6 to stimulate the phosphohydrolytic activity of AHA1 H+-ATPase. Purified yeast ER vesicles (10 µg) were incubated with different concentrations of wild-type or mutated GF14-6 proteins in the presence of 10 µM FC. black-diamond , wild type; black-square, K56E; black-triangle, K56Q; , K56R; open circle , V185E. Data are the mean of three independent experiments.

Effect of the D938A/D940A Double Mutation and the T947E Mutation, Both in the H+-ATPase C Terminus, on FC-dependent Interaction with GF14-6-- R18 is a synthetic peptide selected from a phage display library for its ability to bind 14-3-3 proteins in a phosphorylation-independent manner (32). It has been proposed that binding property is due to the motif WLDLE. Interestingly, in the H+-ATPase C terminus a very similar sequence, namely 936GLDID (numbered according to MHA2 isoform), located close to the C-terminal end is present. To verify whether this sequence could be involved in the phosphorylation-independent, FC-dependent interaction, single and double mutation of the two acidic residues, Asp938 and Asp940, were obtained.

The wild-type and mutated C-terminal domains were expressed in E. coli as GST-fusion proteins and assayed for their ability to interact with 32P-labeled GF14-6 in overlay experiments, in the presence of 10 µM FC.

As shown in Fig. 8A, mutation D940A (lane 3) did not affect the binding of recombinant H+-ATPase C terminus, mutation D938A (lane 2) reduced the binding, and double mutation (lane 4) completely abolished it. These results demonstrated the relevance of the two negatively charged residues for the FC-dependent interaction with GF14-6.


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 8.   Role of negative charges in the H+-ATPase C terminus in the FC-dependent interaction with GF14-6. MHA2 GST-C terminus mutants were subjected to overlay assay using 32P-labeled GF14-6 as a probe. A, wild-type GST-C-terminal domain of MHA2 H+-ATPase (lane 1), D938A mutant (lane 2), D940A mutant (lane 3), and D938A-D940A double-mutant (lane 4) were assayed in overlay assay in the presence of 10 µM FC. B, comparison between wild-type GST-C-terminal domain of MHA2 H+-ATPase (lane 1) and T947E mutant (lane 2) in the interaction with 32P-labeled GF14-6 in the absence or in the presence of 10 µM FC. The minor signal intensity of MHA2 wild-type C-terminal domain, compared with that shown in A, is due to a shorter time of exposure of the autoradiography.

A further indication of the importance of negative charges in the FC-dependent interaction was obtained by means of the T947E mutant. It contains a negatively charged residue in place of the phosphorylatable threonine residue, within the YTV 14-3-3 binding sequence. This mutant had been produced to verify whether the negative charge of the glutamic acid could mimic the phosphate group. Autoradiography reported in Fig. 8B showed that no interaction occurred between GF14-6 and the mutated C terminus. Surprisingly, however, in the presence of FC, the T947E mutant (lane 2) interacted more efficiently than did the wild-type C-terminal domain.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The plasma membrane H+-ATPase of plant cell is regulated by 14-3-3 proteins. It contains the 14-3-3 binding motif YTV, located at the extreme end of the C-terminal autoinhibitory region of the enzyme. This is a novel sequence completely unrelated to the well characterized mode-1 and mode-2 motifs, which accounts for most of 14-3-3 interactions with target proteins. Hence, we were interested in identifying residues important for binding activity of a plant 14-3-3 protein and ascertaining whether the interaction with the H+-ATPase underlies the same mechanism reported for the interaction with canonical motifs (9, 15). To this purpose, single amino acid mutations known to affect the binding properties of animal 14-3-3 proteins were reproduced in the plant 14-3-3 isoform GF14-6, and their effects on the ability to interact with and to activate the H+-ATPase were investigated.

In this study, we show that K56E and V185E mutations drastically hamper the interaction of GF14-6 with the H+-ATPase. These results indicate that Lys56 and Val185 are both crucial for binding to the YTpV sequence, thereby suggesting that basic and hydrophobic clusters in the conserved amphipathic groove of 14-3-3 are involved also in this interaction. This finding is worth noting, because the H+-ATPase binding site lacks the main features of classical consensus sequences, namely a basic residue at the -3/-4 position as well as a proline at the +2 position. It has been suggested that the proline residue is important to fold the binding site, allowing the entrance of the C-terminal portion back toward to the binding groove (33); probably in the H+-ATPase the localization of the phosphoamino acid residue at the extreme C-terminal end of the protein renders the role of the proline residue unnecessary. Interestingly, the 14-3-3 binding sequence GHSL of the glycoprotein Ib-IX-V complex protein (34), which also lacks the proline at +2 Sp position, is likewise located at the extreme C-terminal end of the protein.

The importance of a positively charged residue at position 56 of GF14-6 has been further probed by substituting the Lys residue with a Gln or Arg residue. In comparison with the mutation K56E, the polar K56Q partially, and the conservative K56R completely, restored the binding activity. Interestingly, efficiencies of H+-ATPase stimulation by mutants directly paralleled binding affinities.

The interaction mechanism with H+-ATPase was further investigated by studying the binding of wild-type and mutant GF14-6 to the bL15Vp peptide, reproducing the last 15 residues of MHA2 H+-ATPase and containing the YTpV sequence. The results were in good agreement with those observed with the whole enzyme in the overlay experiments. However, the K56R mutant, compared with the wild-type GF14-6, displays a much higher affinity toward the bL15Vp peptide than to the H+-ATPase. A possible explanation is that the bL15Vp peptide does not exactly match the conformational features occurring in the whole enzyme, which can be important in the physiological interaction of the enzyme.

It is worth noting that no FC effect was detected when the interaction studies were performed with the MHA2-776p peptide, which reproduces a putative 14-3-3 binding site in the H+-ATPase (28) related to a mode-1 binding motif. This strongly suggests that the ability to bind FC is a unique feature of the complex between 14-3-3 protein and the extreme portion of the C-terminal domain of the proton pump.

FC strongly stabilizes the interaction between 14-3-3 and the H+-ATPase and brings about 14-3-3 binding also in the absence of enzyme phosphorylation. The results of the overlay assay with the recombinant unphosphorylated C-terminal domain of the H+-ATPase demonstrated that Lys56 and Val185 are both essential for FC-induced binding. This indicates that the same amphipathic 14-3-3 binding groove is involved also in the FC-dependent interaction, occurring in the absence of phosphorylation. This result appears particularly relevant because it has been observed that binding with unphosphorylated 14-3-3 targets does not required the same hydrophobic residues involved in the interaction with phosphorylated proteins (35).

It has been proposed (9) that the function of the basic cluster in 14-3-3 proteins is to interact with the negatively charges of the phosphoamino acid within the binding site; in this respect, the question is open about the effect of Lys56 mutation, which abolishes the binding also in the absence of phosphorylation of the C-terminal domain of the H+-ATPase. An explanation for this result was obtained by studying the effect of point mutation of the H+-ATPase C terminus. In fact, substitution of the two Asp with Ala residues, within the sequence 936GLDID (numeration according to MHA2 isoform) located close to the YTV sequence, completely abolished the ability of recombinant C-terminal domain of H+-ATPase to bind GF14-6 in the presence of FC. This demonstrates that negative charges play a role also in the FC-dependent interaction, probably mimicking the phosphate group function in the 14-3-3/target complex formation. This hypothesis has also been proposed for the unphosphorylated R18 peptide, which contains the very similar sequence WLDLE; in fact, in the 14-3-3zeta /R18 complex, the two Asp and Glu acidic residues of peptide are located next to the basic cluster of the 14-3-3 protein (15). Intriguingly exoenzyme S, which interacts with 14-3-3 proteins in a phosphorylation-independent manner, possesses a homologous motif, 245FGADAE, in its C-terminal region (12).

The role of negative charges in the FC-dependent interaction can also be inferred from data obtained with the T947E mutant. In fact, the introduction of a further negatively charged residue brought about a marked increase in the ability to bind 14-3-3 protein.

In conclusion, our data show that positively charged residues in GF14-6 binding groove and negatively charged residues in the C-terminal domain of H+-ATPase play a crucial role in binding between these proteins, even when, as in the FC-dependent interaction, it occurs in the absence of H+- ATPase phosphorylation.

    ACKNOWLEDGEMENTS

We thank Prof. M.G. Palmgren for the gift of the yeast strain expressing the AHA1 H+-ATPase. We are grateful to Banca di Roma for funding the purchase of the plant growth chamber.

    FOOTNOTES

* This work has been supported by the Italian Ministry of University and Scientific Research (Cofimanziamento 2000), by the National Research Council (Consiglio Nazionale delle Ricerche Target Project on Biotechnology) and by Piano Nazionale Ricerche Biotecnologie avanzate II tema 4.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed. Tel.: 39-06-72594343; Fax: 39-06-2023500; E-mail: aducci@uniroma2.it.

Published, JBC Papers in Press, December 30, 2002, DOI 10.1074/jbc.M211039200

    ABBREVIATIONS

The abbreviations used are: FC, fusicoccin; GST, glutathione-S-transferase; ER, endoplasmic reticulum; MHA2, Maize H+-ATPase isoform 2; AHA1, Arabidopsis thaliana H+-ATPase isoform 1.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Palmgren, M. G., Fuglsang, A. T., and Jahn, T. (1998) Exp. Biol. Online 3, 4
2. Finnie, C., Borch, J., and Collinge, D. B. (1999) Plant Mol. Biol. 40, 545-554[CrossRef][Medline] [Order article via Infotrieve]
3. Roberts, M. R. (2000) Curr. Opin. Plant Biol. 3, 400-405[CrossRef][Medline] [Order article via Infotrieve]
4. Fu, H., Subramanian, R. R., and Masters, S. C. (2000) Annu. Rev. Pharmacol. Toxicol. 40, 617-647[CrossRef][Medline] [Order article via Infotrieve]
5. van Hemert, M. J., Steensma, H. Y., and van Heusden, G. P. H. (2001) BioEssays 23, 936-946[CrossRef][Medline] [Order article via Infotrieve]
6. Aducci, P., Camoni, L., Marra, M., and Visconti, S. (2002) Int. Union Biochem. Mol. Biol. Life 53, 49-55
7. Sehnke, P. C., DeLille, J. M., and Ferl, R. J. (2002) Plant Cell S339-S340
8. Muslin, A. J., Tanner, J. W., Allen, P. M., and Shaw, A. S. (1996) Cell 84, 889-897[Medline] [Order article via Infotrieve]
9. Yaffe, M. B., Rittinger, K., Volinia, S., Caron, P. R., Aitken, A., Leffers, H., Gamblin, S. J., Smerdon, S. J., and Cantley, L. C. (1997) Cell 91, 961-971[Medline] [Order article via Infotrieve]
10. Du, X., Fox, J. E., and Pei, S. (1996) J. Biol. Chem. 271, 7362-7367[Abstract/Free Full Text]
11. Clark, G. J., Drugan, J. K., Rossman, K. L., Carpenter, J. W., Rogers-Graham, K., Fu, H., Der, C. J., and Campbell, S. L. (1997) J. Biol. Chem. 272, 20990-20993[Abstract/Free Full Text]
12. Masters, S. C., Pederson, K. J., Zhang, L., Barbieri, J. Y., and Fu, H. (1999) Biochemistry 38, 5216-5221[CrossRef][Medline] [Order article via Infotrieve]
13. Liu, D., Bienkowska, J., Petosa, C., Collier, R. J., Fu, H., and Liddington, R. (1995) Nature 376, 191-194[CrossRef][Medline] [Order article via Infotrieve]
14. Xiao, B., Smerdon, S. J., Jones, D. H., Dodson, G. G., Soneji, Y., Aitken, A., and Gamblin, S. (1995) Nature 376, 188-191[CrossRef][Medline] [Order article via Infotrieve]
15. Petosa, C., Masters, S. C., Bankston, L. A., Pohl, J., Wang, B., Fu, H., and Liddington, R. C. (1998) J. Biol. Chem. 273, 16305-16310[Abstract/Free Full Text]
16. Zhang, L., Wang, H., Liu, D., Liddington, R., and Fu, H. (1997) J. Biol. Chem. 272, 13717-13724[Abstract/Free Full Text]
17. Wang, H., Zhang, L., Liddington, R., and Fu, H. (1998) J. Biol. Chem. 273, 16297-16304[Abstract/Free Full Text]
18. Fuglsang, A. T., Visconti, S., Drumm, K., Jahn, T., Stensballe, A., Mattei, B., Jensen, O. N., Aducci, P., and Palmgren, M. G. (1999) J. Biol. Chem. 274, 36774-36780[Abstract/Free Full Text]
19. Svennelid, F., Olsson, A., Piotrowski, M., Rosenquist, M., Ottman, C., Larsson, C., Oecking, C., and Sommarin, M. (1999) Plant Cell 11, 2379-2391[Abstract/Free Full Text]
20. Camoni, L., Iori, V., Marra, M., and Aducci, P. (2000) J. Biol. Chem. 275, 9919-9923[Abstract/Free Full Text]
21. Aducci, P., Marra, M., Fogliano, V., and Fullone, M. R. (1995) J. Exp. Bot. 46, 1463-1478
22. Fullone, M. R., Visconti, S., Marra, M., Fogliano, V., and Aducci, P. (1998) J. Biol. Chem. 273, 7698-7702[Abstract/Free Full Text]
23. Ballio, A., Carilli, A., Santurbano, B., and Tuttobello, L. (1968) Ann. First Super. Sanità 4, 317-332
24. Ballio, A., Federico, R., Pessi, A., and Scalorbi, D. (1980) Plant Sci. Lett. 18, 39-44
25. Marra, M., Fogliano, V., Zambardi, A., Fullone, M. R., Nasta, D., and Aducci, P. (1996) FEBS Lett. 382, 293-296[CrossRef][Medline] [Order article via Infotrieve]
26. Frias, I., Caldeira, M. T., Pérez-Castiñeira, J. R., Navarro-Aviño, J. P., Culiañez-Maciá, F. A., Kuppinger, O., Stransky, H., Pagés, M., Hager, A., and Serrano, R. (1996) Plant Cell 8, 1533-1544[Abstract/Free Full Text]
27. Regenberg, B., Villalba, J. M., Lanfermeijer, F. C., and Palmgren, M. G. (1995) Plant Cell 7, 1655-1666[Abstract/Free Full Text]
28. Marra, M., Olivari, C., Visconti, S., Albumi, C., Aducci, P., and De Michelis, M. I. (2000) Plant Biol. 2, 1-6[CrossRef]
29. Laemmli, U. K. (1970) Nature 277, 680-685
30. Serrano, R. (1989) Methods Enzymol. 157, 533-544
31. Bradford, M. M. (1976) Anal. Biochem. 72, 248-254[CrossRef][Medline] [Order article via Infotrieve]
32. Wang, B., Yang, H., Liu, Y., Jelinek, T., Zhang, L., Rouslahti, E., and Fu, H. (1999) Biochemistry 38, 12499-12504[CrossRef][Medline] [Order article via Infotrieve]
33. Rittinger, K., Budman, J., Xu, J., Volinia, S., Cantley, L. C., Smerdon, S. J., Gamblin, S. J., and Yaffe, M. B. (1999) Mol. Cell 4, 153-166[Medline] [Order article via Infotrieve]
34. Andrews, R. K., Harris, S. J., McNally, T., and Berndt, M. C. (1998) Biochemistry 37, 638-647[CrossRef][Medline] [Order article via Infotrieve]
35. Zhang, L., Wang, H., Masters, S. C., Barbieri, J. T., and Fu, H. (1999) Biochemistry 38, 12159-12164[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.



This Article
Abstract
Full Text (PDF)
All Versions of this Article:
278/10/8172    most recent
M211039200v1
Purchase Article
View Shopping Cart
Alert me when this article is cited
Alert me if a correction is posted
Citation Map
Services
Email this article to a friend
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Copyright Permissions
Google Scholar
Articles by Visconti, S.
Articles by Aducci, P.
Articles citing this Article
PubMed
PubMed Citation
Articles by Visconti, S.
Articles by Aducci, P.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   Biochemistry and Molecular Biology Education 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.